Generated by GPT-5-mini| epigenetics | |
|---|---|
![]() National Institutes of Health · Public domain · source | |
| Name | Epigenetics |
| Field | Genetics, Molecular Biology |
| Discovered | 1942 |
| Notable people | Conrad Waddington, Arthur Kornberg, Sydney Brenner, Francis Crick, Matt Ridley |
epigenetics Epigenetics studies heritable changes in gene expression that do not involve alterations to the DNA sequence itself. It examines how chemical modifications, chromatin organization, and nuclear architecture regulate transcriptional activity across development, physiology, and disease. Research in the field connects experiments from laboratories led by James Watson-era institutions, clinical observations at centers like Mayo Clinic, and population studies involving cohorts from Framingham Heart Study and UK Biobank.
The concept originated in synthesis between developmental biology and genetics during the mid-20th century with figures such as Conrad Waddington and experimental techniques advanced by laboratories associated with Arthur Kornberg and Sydney Brenner. Modern work integrates inputs from groups at National Institutes of Health, Wellcome Trust, and university departments such as Harvard University, Stanford University, and Massachusetts Institute of Technology. Fields intersecting with the topic include clinical genomics at Broad Institute, computational biology at European Bioinformatics Institute, and population genetics projects like 1000 Genomes Project. Major collaborative efforts and consortia—ENCODE Project, Roadmap Epigenomics Project, and initiatives at European Molecular Biology Laboratory—drive standards for annotation and reproducibility.
Key molecular mechanisms involve covalent modifications of chromatin components discovered in labs influenced by work at Cold Spring Harbor Laboratory and techniques developed by researchers in the tradition of Max Delbrück and Salvador Luria. Core mechanisms include: - DNA methylation at cytosine residues established by enzymes related to discoveries in groups such as Salk Institute and Pasteur Institute. - Post-translational histone modifications (acetylation, methylation, phosphorylation) characterized using mass spectrometry methodologies refined at Rockefeller University and analytic platforms from EMBL-EBI. - Chromatin remodeling by ATP-dependent complexes traced to work in laboratories like Johns Hopkins University and University of California, San Francisco. - Non-coding RNA–mediated regulation, studied by teams at Cold Spring Harbor Laboratory and Cambridge University. - Higher-order nuclear architecture, including topologically associating domains (TADs), elucidated with contributions from groups at Broad Institute and Max Planck Institute.
Epigenomic mapping and manipulation techniques have been developed and standardized through collaborations among institutions such as Wellcome Sanger Institute and companies like Illumina. Representative methods include: - Bisulfite sequencing and whole-genome bisulfite sequencing protocols used in projects at Genome Canada and NIH. - Chromatin immunoprecipitation followed by sequencing (ChIP-seq) implemented in labs at University of Oxford and Yale University. - Assay for transposase-accessible chromatin using sequencing (ATAC-seq) pioneered by teams linked to Stanford University and applied in clinical studies at Massachusetts General Hospital. - Hi-C and related 3C technologies developed with contributions from European Molecular Biology Laboratory and Broad Institute. - Epigenome editing using CRISPR-dCas9 platforms advanced in labs at UC Berkeley and startups emerging from MIT spinouts.
Epigenetic regulation underlies processes first characterized in classic developmental studies at institutions such as University of Cambridge and Columbia University. Examples include: - X-chromosome inactivation characterized by research tracing back to labs affiliated with University of Oxford and Cold Spring Harbor Laboratory. - Genomic imprinting phenomena explored in studies at Cambridge University and Harvard Medical School implicating imprinted loci like those analyzed in cohorts from Danish Twin Registry. - Cellular differentiation programs mapped in pluripotent stem cell work at Karolinska Institute and Salk Institute. - Aging-associated epigenetic drift quantified in longitudinal cohorts run by Framingham Heart Study and population studies like UK Biobank. - Plant epigenetic responses dissected in projects at John Innes Centre and Max Planck Institute for Plant Breeding Research.
Aberrant epigenetic states have been linked to disorders investigated in clinical centers such as Mayo Clinic and Johns Hopkins Hospital. Examples include: - Cancer epigenomes profiled extensively by teams at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, informing therapies targeting DNA methylation and histone modifiers. - Neurological and psychiatric conditions studied at National Institute of Mental Health and Stanford University School of Medicine showing epigenetic contributions to disease risk. - Metabolic and cardiovascular disease associations explored in collaborations with Framingham Heart Study and translational research at Cleveland Clinic. - Developmental syndromes with epigenetic etiologies identified through genetic clinics at Great Ormond Street Hospital and research consortia like Deciphering Developmental Disorders.
Environmental exposures studied by teams at Imperial College London, Harvard T.H. Chan School of Public Health, and NIH demonstrate epigenetic responses to factors such as nutrition, toxins, and stress. Notable population studies include cohorts from Avon Longitudinal Study of Parents and Children and ALSPAC investigating prenatal influences. Evidence for intergenerational and transgenerational transmission of epigenetic states has been examined in model systems from labs at University of Zurich and Max Planck Institute for Biology of Ageing, and debated in the context of epidemiological data from Hokkaido Study and Dutch Hunger Winter cohorts.